Faculty

Institution

Unit

Venue

Melissa L. Larson

Rush University

Affiliations

Rush Medical College

Department Of Internal Medicine

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMelissa L. Larson is currently serving as a Internal Medicine faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Melissa L. Larson

Rush University

You can click a keyword to filter the displayed items

medicine hematology leukemia hematological malignancies oncology pharmacology immunology cancer research lymphoid neoplasia pharmacotherapy myeloid neoplasia pathology cancer care acute myeloid leukemia clinical research cancer treatment therapeutic targets medicinal research cellular therapy laboratory medicine clinical transplantation respiratory medicine cell therapy immunotherapy experimental medicine cell research cytogenetics stem cell transplantation race surgical oncology internal medicine health disparities health care disparities cancer disparities malignant blood disorders autoimmune diseases medical mycology histopathology health inequalities clinical therapeutics cancer management lymphatic disease blood cells treatment plan evaluation eligibility criteria liposome injection structural racism older patients clinical rheumatology jama oncology novel therapies therapy resistance metronomic therapy adult t-cell leukemia-lymphoma inborn errors of immunity disease susceptibility granulocyte immunohaematology immunologic diseases racial equity insulin signaling viral oncology clinical mycology randomized controlled trials drug trials phase ii intensive salvage therapy first relapse aml core-binding factor secondary cytogenetic abnormalities cll/sll patients aggressive disease cytokine dysregulation erythroid differentiation final safety efficacy results

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing Drivers of Disparate Outcomes and Applicability of Risk Stratification in a Cohort of Patients With Myelofibrosis. Blood Cancer Journal (2025)

risk stratificationprospective cohort studiesprognosiscohort studiesclinical epidemiologyprognostic evaluationdisparate outcomesoutcomes researchdisease risk assessmentmortalityhealth sciencesepidemiology

Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials. Blood (2025)

medicinetreatment plan evaluationeligibility criteriadrug trialshematological malignancieshealth careleukemiahealth policyhealth services researchcancer carerandomized controlled trialsclinical trials

The Impact of Environmental Air Exposues on Disease Characteristics and Outcomes in a Cohort of Patients With Myelofibrosis. Blood (2025)

environmental healthhematologymedicineenvironmental exposuresair qualityenvironmental epidemiologyrespiratory medicineair pollutionhealth sciencespulmonary diseasesepidemiology

The Role of Targeted Therapies in Blastic Plasmacytoid Dendritic Cell Neoplasm. Expert Opinion on Biological Therapy (2025)

immunomodulationtumor biologyimmune responsescellular therapycancer researchtargeted therapiescell biologycancer cellsleukemiaimmunotherapyoncogenesimmune checkpoint inhibitorsimmunologycell transplantationtherapeutic targets

Air Pollutant Impact on Disease Characteristics and Outcomes in Patients With Acute Myeloid Leukemia. Blood Advances (2024)

Andrew PalmerGarth RauscherIvy AbrahamMadelyn BurkartAmi DaveNepheli RaptisAhmed AleemVedavyas GannamaniAmani ErraSarah MonickCarlos GalvezSyed ShahHamed Rahmani YoushanloueiMelissa L. LarsonMaryam ZiaStephanie B. TsaiJessica K. AltmanWendy StockIrum KhanAnand A. Patel

hematologymedicineair pollutant impactoncologyveterinary medicinehematological malignanciescancer careacute myeloid leukemiarespiratory medicinedisease characteristicspublic healthsurvival analysishealth sciencesair pollution

Assessing Disparities in a Chicagoland Cohort of Patients With Myelofibrosis. Blood (2024)

Andrew PalmerGarth RauscherAlexa SchoenMadelyn BurkartAshley DuntonCherry AuAmi DaveAhmad NassarShaoshi ZhuAmani ErraVinod SolipuramIvy AbrahamStephanie B. TsaiMaryam ZiaMelissa L. LarsonDamiano RondelliJessica K. AltmanWendy StockIrum KhanOlatoyosi OdenikeAnand Ashwin Patel

hematologycohort studieschicagoland cohortpublic health

Identifying Eligibility Criteria That Perpetuate Race/Ethnic Disparities in Acute Myeloid Leukemia (Aml) Clinical Trial Participation.. Journal of Clinical Oncology (2024)

Andrew HantelYating WangIvy AbrahamAnand Ashwin PatelSarah Elizabeth MonickGarth H RauscherAna Maria Avila RodriguezCarlos GalvezPeter DoukasJessica K. AltmanMadelyn BurkartAmani ErraMaryam ZiaMelissa L. LarsonAmi Atulkumar DaveStephanie TsaiAhmed AleemNepheli RaptisIrum KhanGregory A. Abel

health inequalitiesracial equityracial discriminationeligibility criteriaoncologyracehealth equitycancer disparitieshealth policyhealth disparitieshealth care disparitiesclinical trial participationpublic healthafrican american studiesacute myeloid leukemiaclinical trials

The Impact of Air Pollutants on a Chicagoland Cohort of Patients With Acute Myeloid Leukemia. Blood (2023)

Andrew PalmerGarth RauscherIvy AbrahamMadelyn BurkartAmi DaveNepheli RaptisAhmed AleemVedavyas GannamaniAmani ErraSarah MonickCarlos GalvezMelissa L. LarsonMaryam ZiaStephanie B. TsaiJessica K. AltmanWendy StockIrum KhanAnand Ashwin Patel

hematologyenvironmental healthmedicineoncologyhematological malignanciesrespiratory toxicologyclinical epidemiologylaboratory medicinecancer careacute myeloid leukemiapublic healthair pollutionair pollutantsepidemiology

A Study to Evaluate the Utility and Appropriateness of Diagnostic Workup for Leukocytosis in the Hematology Clinic. Blood (2022)

diagnosishematologymedicinelaboratory hematologyclinical epidemiologylaboratory medicinepediatric hematologyhematology clinicdiagnostic workupclinical researchhealth sciencesclinical laboratory

Measures of Structural Racism Predict Icu Admission Following Intensive Chemotherapy for Aml. Blood (2022)

Ivy AbrahamGarth RauscherAnand Ashwin PatelSarah MonickMadelyn BurkhartEshana ShahAmi DaveMatthew KrollStephanie B. TsaiStephanie BergAmani ErraVedavyas GannamaniMaryam ZiaMelissa L. LarsonWendy StockJessica K. AltmanIrum Khan

intensive careclinical evidenceleukemiarespiratory medicinecritical careoncologycohort studiesicu admissionhealth care disparitiescancer careclinical case presentationneurologytreatment optionssurvival analysisbreast cancerhematologystrategic studiesstructural racismhealth policyclinical researchintensive chemotherapy

1
2
3
4
5
6
7
10 / page

Melissa L. Larson

Rush University

Affiliations

Rush Medical College

Department Of Internal Medicine

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMelissa L. Larson is currently serving as a Internal Medicine faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Melissa L. Larson

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing Drivers of Disparate Outcomes and Applicability of Risk Stratification in a Cohort of Patients With Myelofibrosis. Blood Cancer Journal (2025)

Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials. Blood (2025)

The Impact of Environmental Air Exposues on Disease Characteristics and Outcomes in a Cohort of Patients With Myelofibrosis. Blood (2025)

environmental healthhematologymedicineenvironmental exposuresair qualityenvironmental epidemiologyrespiratory medicineair pollutionhealth sciencespulmonary diseasesepidemiology

The Role of Targeted Therapies in Blastic Plasmacytoid Dendritic Cell Neoplasm. Expert Opinion on Biological Therapy (2025)

Air Pollutant Impact on Disease Characteristics and Outcomes in Patients With Acute Myeloid Leukemia. Blood Advances (2024)

Assessing Disparities in a Chicagoland Cohort of Patients With Myelofibrosis. Blood (2024)

hematologycohort studieschicagoland cohortpublic health

Identifying Eligibility Criteria That Perpetuate Race/Ethnic Disparities in Acute Myeloid Leukemia (Aml) Clinical Trial Participation.. Journal of Clinical Oncology (2024)

The Impact of Air Pollutants on a Chicagoland Cohort of Patients With Acute Myeloid Leukemia. Blood (2023)

A Study to Evaluate the Utility and Appropriateness of Diagnostic Workup for Leukocytosis in the Hematology Clinic. Blood (2022)

diagnosishematologymedicinelaboratory hematologyclinical epidemiologylaboratory medicinepediatric hematologyhematology clinicdiagnostic workupclinical researchhealth sciencesclinical laboratory

Measures of Structural Racism Predict Icu Admission Following Intensive Chemotherapy for Aml. Blood (2022)

1
2
3
4
5
6
7
10 / page